Biden bid on cancer research gets boost in spending deal
WASHINGTON (AP) — Vice President Joe Biden’s self-described “moonshot” to cure cancer is getting a modest boost from a congressional deal on federal spending.
The spending-and-taxes package moving through Congress includes a $2 billion increase for the National Institutes of Health. There’s also $200 million for research into precision medicine, in which disease treatment is customized to the patient. Some of those funds are designated for precision oncology and genomics.
Biden’s office says he worked with key lawmakers to help secure the funding.
In his October speech announcing he wouldn’t run for president, Biden said he’d spend his last year in office pushing for more research and development to end cancer. He hasn’t yet laid out a comprehensive plan to accomplish that.
Biden’s eldest son, Beau Biden, died from brain cancer in May.